JOSEPH SABRA: Open Payments
NPI 1033778626 · WAYNE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,652 in 230 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $432 · 2025 $5,652
Food & beverage: $5,473Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 73 | $1,193 |
| Axsome Therapeutics, Inc. | 18 | $567 |
| SK Life Science, Inc. | 12 | $444 |
| CATALYST PHARMACEUTICALS, INC. | 14 | $346 |
| AstraZeneca Pharmaceuticals LP | 5 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $278 |
| Lundbeck LLC | 9 | $273 |
| UCB, Inc. | 6 | $204 |
| Teva Pharmaceuticals USA, Inc. | 3 | $192 |
| Ipsen Biopharmaceuticals, Inc | 13 | $184 |
Products named: Symbravo, QULIPTA, FYCOMPA, BOTOX, CAPLYTA, VYALEV, VYEPTI, WAINUA.
Industry payments across MI — which companies pay providers there.
